RNAZ
USDTransCode Therapeutics Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$9.910
Haut
$10.450
Bas
$9.500
Volume
0.01M
Fondamentaux de l'Entreprise
Capitalisation Boursière
8.7M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.14M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
TransCode Therapeutics presents preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) announces completion of Phase 1a clinical trial with TTX-MC138, an investigational inhibitor of...
TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) ("TransCode or the "Company") announced today that it entered into a definitive agreement to acquire...
Actions Connexes
NYMTZ
New York Mortgage Trust Inc. 7.000% Series G Cumulative Redeemable Preferred Stock $0.01 par value per share
CCSI
Consensus Cloud Solutions Inc.
LE
Lands' End Inc.
VRSN
VeriSign Inc.
AWP
abrdn Global Premier Properties Fund Common Shares of Beneficial Interest
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.